Advertisement
UK markets close in 6 hours 28 minutes

  • FTSE 100

    8,301.85
    +88.36 (+1.08%)
     

  • FTSE 250

    20,377.96
    +213.42 (+1.06%)
     

  • AIM

    776.95
    +5.42 (+0.70%)
     

  • GBP/EUR

    1.1648
    -0.0011 (-0.10%)
     

  • GBP/USD

    1.2537
    -0.0026 (-0.21%)
     

  • Bitcoin GBP

    51,254.92
    -891.05 (-1.71%)
     

  • CMC Crypto 200

    1,333.13
    -31.99 (-2.34%)
     

  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     

  • DOW

    38,852.27
    +176.59 (+0.46%)
     

  • CRUDE OIL

    78.65
    +0.17 (+0.22%)
     

  • GOLD FUTURES

    2,325.00
    -6.20 (-0.27%)
     

  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     

  • HANG SENG

    18,479.37
    -98.93 (-0.53%)
     

  • DAX

    18,270.12
    +94.91 (+0.52%)
     

  • CAC 40

    8,014.85
    +18.21 (+0.23%)
     
Money:

The retirement income gap no-one is talking about

People are living longer than ever before and this can impact how you plan for retirement

BUZZ-GlaxoSmithKline: hit as 2015 gloom outweighs long-term hope

Reuters - UK Focus

** GlaxoSmithKline (Other OTC: GLAXF - news) second biggest FTSE 100 faller, down 3.4 pct, as analysts downgrade near-term estimates after drugmaker warns of "high teens" percentage fall in 2015 EPS

** Brokerages Bernstein and Bryan Garnier both cut price targets. Bernstein analyst Tim Anderson says 2015 guidance "much worse than our modeling of -5 pct or consensus of -11 pct"

** GSK argued at May 6 investor day it was taking short-term hit in 2015, but expected long-term gain as it reshapes business to ensure reliable growth and secure dividend

(RM (LSE: RM.L - news) : ben.hirschler.thomsonreuters.com@reuters.net)